Novartis Stakes Claim on Potential Drugs From Dana-Farber Institute

Novartis Institutes of BioMedical Research, the Cambridge, Mass.-based R&D unit of Swiss drug giant Novartis, has asserted itself in a lawsuit concerning rights to potentially game-changing drugs for lung cancer discovered at Dana-Farber Cancer Institute in Boston.
Xconomy